| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $77.1B | $71.0B | $19.0B | $69.9B | $71.1B | $19.4B | $17.1B | $15.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $6.1B | $6.0B | — | — | — | — | — | — |
| Net Income | $3.4B | $4.4B | $0.6B | $2.5B | $6.6B | $0.2B | $0.6B | $2.1B |
| EPS (Basic) | $4.74 | $5.98 | $0.78 | $2.93 | $7.36 | $0.14 | $0.58 | $2.05 |
| EPS (Diluted) | $4.71 | $5.94 | $0.77 | $2.91 | $7.31 | $0.14 | $0.58 | $2.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $745.2B | $677.5B | $687.6B | $666.6B | $759.7B | $795.1B | $740.5B | $687.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $22.0B | $20.1B | $20.6B | $20.2B | $20.0B | $19.8B | $16.6B | $15.8B |
| Total Liabilities | $716.2B | $649.8B | $657.3B | $639.3B | $692.0B | $720.3B | $674.1B | $634.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $28.4B | $27.4B | $30.0B | $27.0B | $67.5B | $74.6B | $66.1B | $52.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.1B | $14.6B | $13.7B | $13.2B | $12.6B | $11.6B | $13.8B | $11.7B |
| Investing Cash Flow | $-15.6B | $-11.5B | $-10.2B | $-2.6B | $-11.2B | $-18.6B | $-17.6B | $-5.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $-3.1B | $-2.9B | $-10.1B | $-1.4B | $10.7B | $4.6B | $-2.8B |